Received Sep 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 2 | — | — |
Physician called to report a set of twins got the GARDASIL 9 vaccine and didn't follow the recommended schedule, Female patient had first dose 6/27/2024, 1/8/2025, but never received the third dose.; No side effects or symptoms reported; This spontaneous report was received from a physician and referred to a female patient of unknown age. The patient's medical history, concurrent condition, and concomitant therapy were not reported. On 27-Jun-2024 (when the patient was 17 years old), the patient vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (strength, does, frequency, route, lot # and expiration date were not reported) for prophylaxis. On 08-Jan-2025, the patient vaccinated with the second dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) (strength, does, frequency, route, lot # and expiration date were not reported) for prophylaxis. The patient never received the third dose (Inappropriate schedule of vaccine administered). No side effects or symptoms reported. Lot# is being requested and will be submitted if received. This is one of two cases from the same reporter.